SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aprameya Engineering Ltd (APRAMEYA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: APRAMEYA Trading | Small Cap | Aprameya Engineering Share Price

BSE Share Price
Not Listed

Aprameya Engineering Ltd (APRAMEYA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: APRAMEYA Trading | Small Cap | Aprameya Engineering Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹310 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹2.7
TTM Sales
₹54.8 Cr.
Book Value per Share
₹36.4
P/E Ratio
61.60
Higher than its 3-year historical median
Industry PE
36
Price to Book (P/B)
4.48
Higher than its 3-year historical median
Price to Sales (P/S)
5.67
Higher than its 3-year historical median
EV/EBITDA
31.11
Higher than its 3-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
36.77%
Outperforms industry median
Return on Capital Employed (ROCE)
31.11%
Outperforms industry median
Return on Assets (ROA)
14.74%
Operating Profit Margin
18%
Net Profit Margin
11.88%
Gross Profit Margin
15.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
108.27%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
283.65%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
361.89%
Asset Quality
Promoter Holding
74.05%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹50 Cr.
Equity
₹19 Cr.
Face Value
₹10
All Time Low / High
- / -

Aprameya Engineering stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Aprameya Engineering Ltd a good quality company?
Aprameya Engineering Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Aprameya Engineering Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Aprameya Engineering Ltd vs industry peers?
Aprameya Engineering Ltd revenue CAGR is -12.12%, compared to the industry median CAGR of 4.99%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Aprameya Engineering Ltd?
Promoters hold 74.05% of the Aprameya Engineering Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Aprameya Engineering Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 34.6% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aprameya Engineering Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'16Mar'17Mar'18Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%88.8%24.9%11.8%31.1%-
Value Creation
Index
NANANA5.30.8-0.21.2-

Growth Parameters

Sales 00020078.165.213655
Sales YoY Gr.-NANANA-60.9%-16.6%108.3%-
Adj EPS 00011.93.82.58.52.7
YoY Gr.-NANANA-67.7%-35.2%239.8%-
BVPS (₹) 00010.414.216.733.836.4
Adj Net
Profit
00016.65.43.516.15
Cash Flow from Ops. 000-0.4-13.5-10-10.6-
Debt/CF from Ops. 000-37.2-2.1-4.2-2.9-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA-12.1%108.3%
Adj EPS NANA-10.7%239.8%
BVPSNANA48.2%101.9%
Share Price - - - -9.6%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
000114.431.216.136.87.6
Op. Profit
Mgn %
00012.412.19.818NAN
Net Profit
Mgn %
0008.36.95.411.99.2
Debt to
Equity
0000.91.41.80.5-
Working Cap
Days
00002423632770
Cash Conv.
Cycle
00001202581660

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales2007865136
Operating Expenses + 1756959111
Manufacturing Costs93493496
Material Costs648173
Employee Cost 3333
Other Costs 15959
Operating Profit 259624
Operating Profit Margin (%) 12.4%12.1%9.8%18.0%
Other Income + 0001
Exceptional Items 0000
Interest 1223
Depreciation 0000
Profit Before Tax 247522
Tax 8216
Profit After Tax 175316
PAT Margin (%) 8.3%6.9%5.4%11.9%
Adjusted EPS (₹)11.93.82.58.5
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Aprameya Engineering - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 15202364
Share Capital 7141419
Reserves 86945
Debt +13284030
Long Term Debt1312126
Short Term Debt0162824
Minority Interest0000
Trade Payables189740
Others Liabilities 3559
Total Liabilities 496275143

Fixed Assets

Net Fixed Assets +1111
Gross Block2222
Accumulated Depreciation0000
CWIP 0000
Investments 0000
Inventories7837
Trade Receivables274258119
Cash Equivalents 3131
Others Assets 1010914
Total Assets 496275143

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0-13-10-11
PBT 247522
Adjustment 1223
Changes in Working Capital -18-21-15-31
Tax Paid -7-3-2-4
Cash Flow From Investing Activity + -3-2-1-0
Capex -1-0-1-0
Net Investments -2-2-1-1
Others 0001
Cash Flow From Financing Activity + 5131111
Net Proceeds from Shares 00025
Net Proceeds from Borrowing 1-02-8
Interest Paid -1-2-2-2
Dividend Paid 0000
Others 61512-4
Net Cash Flow 2-20-0

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)114.3831.1716.1136.77
ROCE (%)88.7824.8711.7931.11
Asset Turnover Ratio4.121.420.951.27
PAT to CFO Conversion(x)-0-2.6-3.33-0.69
Working Capital Days
Receivable Days48.70160279.30232.60
Inventory Days13.6035.8031.5013.90
Payable Days102.40636.80167.502,562.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aprameya Engineering Ltd FAQs

The current trading price of Aprameya Engineering on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Aprameya Engineering stood at ₹310.4 Cr

The latest P/E ratio of Aprameya Engineering as of 31-Dec-1969 is 61.60.

The latest P/B ratio of Aprameya Engineering as of 31-Dec-1969 is 4.48.

The 52-week high of Aprameya Engineering is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aprameya Engineering is ₹54.75 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aprameya Engineering Ltd is a below average quality company.

The key valuation ratios of Aprameya Engineering Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aprameya Engineering Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Aprameya Engineering Ltd

The company was originally formed as a partnership firm in the name and style of ‘Aprameya Engineering’ pursuant to a deed of partnership dated September 05, 2003, registered as on August 13, 2004 vide Registration certificate issued by Registrar of Firms, Ahmedabad City, Ahmedabad under the provisions of the Indian Partnership Act, 1932. Subsequently, the company was incorporated pursuant to a certificate of incorporation dated December 28, 2021 issued by the Registrar of Companies, Central Registration Centre following the conversion of the partnership firm ‘Aprameya Engineering’ to a Private Limited Company. Further, pursuant to special resolution passed by the shareholders of the company at the Extra Ordinary General Meeting, held on April 22, 2022, the company was converted into a Public Limited Company and consequently the name of the company was changed from ‘Aprameya Engineering Private Limited’ to ‘Aprameya Engineering Limited’ vide a fresh certificate of incorporation consequent upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad, Gujarat.

Aprameya Engineering started the business as a partnership firm on September 05, 2003 and has grown its business with the objective of delivering healthcare solutions focused on cost effectiveness and improved accessibility. It is engaged in selling of high value medical equipment as a dealer of medical equipment manufacturers and suppliers such as Johnson & Johnson, Stryker India and many other medical equipment manufacturers. Apart from these companies it also has established cordial relationship with medical device manufacturers like Alan Electronic Systems, Draeger Medical India, Siemens Healthcare, Schiller Healthcare India, Epsilon, Resmed and many other medical devices manufacturers and suppliers for easy and timely procurement. With the knowledge and experience of over one & half decade in delivering the medical devices for patient care at reasonable outlay, it has during the year 2020 expanded its business activity by providing turnkey healthcare infrastructure solution by setting-up of ICU, NICU, PICU, operation theater projects and prefabricated structure ward on turnkey basis. Further, during the year 2024, it has undertaken setting up, installing and commissioning of dialysis centres across the state of Rajasthan.

Business area of the company

The company is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward in the hospitals and medical care centres on turnkey basis along with supply of high value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals and medical practitioners. Over the years, on the basis of its knowledge and understanding of the requirements of medical practitioners, industry standards and utility of the medical equipment, it has evolved ourselves and developed its capabilities in offering solutions in the field of healthcare services relating to ICU set up, dialysis centres setup, operation theatre setup and providing medical equipment for easing operation related to patient treatment, monitoring and diagnosis by hospitals, medical practitioners and diagnostic service providers. The company is engaged in the business of setting up of medical, healthcare infrastructure, supply of consumables, trading of medical and healthcare equipment’s and maintenance of the equipment supplied and installed by the company. Further, the company has many times received commission from the equipment suppliers for supply of the medical equipment directly to the customers.

Key awards, accreditations or recognitions

  • 2015: Received Certificate of Excellence (Silver Category, Year: 2015) in the Stryker Dealer Meet, 2016.
  • 2015: Won Best Performer of the Year 2014-15 award from Alan Electronics Systems. 
  • 2021: received Certificate of Appreciation of Top Annual Sales Performance 2021 from Draeger Medical India Private Limited.
  • 2021: Received Certificate of Achievement: 2nd Runner up: Best Sales Performance for the year 2020 issued at April 9, 2021 from Alan Electronics Systems.
  • 2022: Received Certificate of Achievement: 2nd Runner up: Sales Performance for the year 2021-22 Issued at April 23, 2022 from Alan Electronics Systems.
  • 2022: Received Certificate and Achievement for outstanding and Exemplary Contribution during the year 2022 from Stryker India Private Limited.
  • 2022: Received Certificate of Achievement – Quota Achiever from Stryker India Private Limited.

Major events and milestones

  • 2003: Partnership Firm in the name and style of Aprameya Engineering founded by Chetan Mohan Joshi and Saurabh Kishorbhai Bhatt.
  • 2004: The firm entered into a distributorship agreement with Johnson & Johnson Private Limited.
  • 2004: The firm entered into an agreement with Alan Electronic System Private Limited for completing the Market of ELSY 360 series Diathermy Equipment being manufactured by them.
  • 2009: Entered into agreement with Karl Storz Endoscopy India Private Limited for supplying of medical equipment to the Rajasthan Government.
  • 2020: Commencement of business related to setting up of ICU/OT/PICU/NICU.
  • 2020: Received the first tender for supply and installation of Operation Theatre on turnkey basis for S.M.S. Medical College, Jaipur.
  • 2021: Incorporation of the company as ‘Aprameya Engineering Private Limited’ pursuant to the Conversion of Partnership firm into the Private Company as per the provisions of the Companies Act, 2013.
  • 2022: Achieved a total income of Rs 20,000 lakh.
  • 2022: Started with setting up of Minilabs for ICU/OT/PICU/NICU.
  • 2023: Supply of Johnson & Johnson product Harmonic Scalpel (Gen 11) to AIIMS across India.
  • 2024: Successfully Setting Up of 175 dialysis Centers across Government Hospitals in the state of Rajasthan.
  • 2024: Secured Order from Gujarat Government for Renovation and Comprehensive Annual Maintenance Contract of Modular Operation Theatre in 5 Medical College Hospitals across Gujarat.


To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×